What it takes to make cancer research more inclusive
Drug Discovery World
AUGUST 16, 2022
In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. To resolve this discrepancy, pharma sponsors of clinical studies are now actively working towards decentralising trials to make patient participation easier.
130 
Let's personalize your content